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1991-7902/Copyrightª 2014, AssociatioAbstract Background/purpose: In prior studies, we induced the antimicrobial activity of de-
glycyrrhizinated licorice root extract (DG-LRE) by inhibiting the growth and biofilm formation
of Streptococcus mutans UA159. Here, we used clinical strains of mutans streptococci (MS)
collected from Koreans to determine the optimal concentration of DG-LRE for oral hygiene
products to prevent dental caries.
Materials and methods: Antimicrobial effects of DG-LRE against 14 clinical strains of MS were
evaluated through the minimum inhibitory concentration, minimum bactericidal concentra-
tion, time-kill assay, and biofilm-forming assay.
Results: Minimum inhibitory concentration and minimum bactericidal concentration values of
DG-LRE against the clinical strains of MS ranged from 4 mg/mL to 8 mg/mL and from 8 mg/mL to
16 mg/mL, respectively. Time-kill assay demonstrated that the antimicrobial effects of DG-LRE
primarily resulted from bactericidal activity. DG-LRE significantly decreased the biofilm forma-
tion of S. mutans ranging from 57.6% to 92.8% at 16 mg/mL.
Conclusion: These findings reveal that a DG-LRE concentration of 16 mg/mL may be used to
prevent dental caries in Koreans.
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Mutans streptococci (MS) have been implicated as a caus-
ative agent of dental caries. Inhibition of MS growth and
biofilm formation, therefore, remains an intriguing target
for the prevention of dental caries.1,2 MS represents seven
species characterized by the 16S ribosomal RNA gene:
Streptococcus mutans, Streptococcus sobrinus, Strepto-
coccus downei, Streptococcus rattus, Streptococcus crice-
tus, Streptococcus ferus, and Streptococcus macacae.3 Of
these, S. mutans and S. sobrinus are commonly found in the
human oral cavity and have been implicated as primary
agents in human dental caries.1,4
Many antimicrobials have been used to prevent dental
caries. Chlorhexidine is generally accepted as the gold
standard in the dental field due to its clinical efficacy on a
wide range of oral microorganisms. Regular use of chlor-
hexidine as an antimicrobic, however, is limited due to its
common side effects, such as the formation of extrinsic
tooth and tongue staining.5,6 As a result, considerable in-
terest exists in developing new antimicrobial agents for the
control of dental caries.
Recently, several plants have been examined for their
potential in preventing dental caries.7,8 Licorice (Glycyr-
rhiza glabra, Glycyrrhiza inflata, and Glycyrrhiza ura-
lensis) is one such plant. Traditionally, licorice root has
been used in China and Italy to purportedly lengthen life-
span, improve overall health, cure injury and swelling,
and detoxify.9 Licorice root extract contains significant
amounts of glycyrrhizin, a triperpenoid saponin.10 Glycyr-
rhizin is converted by human intestinal bacteria to glycyr-
rhetic acid, which can induce severe hypertension,
hypokalemia, and mineralocorticoid excess by preventing
renal conversion of cortisol to cortisone.11 It is therefore
important to prepare licorice extract without glycyrrhizin
in order to achieve safe use in humans. In a previous study,
we prepared roots of G. uralensis using a specific resin filter
and obtained an extract without detectable glycyrrhizin.8
Generally, only certain strains of MS have been used to
test the antimicrobial activity of various natural ex-
tracts.8,12 Prior evidence has indicated, however, that
antimicrobial activity differs depending on the MS strain
studied.13,14 This suggests that clinically-relevant strains of
MS in Koreans need to be investigated to aid in preventing
dental caries in Korea. We introduced a bacterial screening
system for preventing dental caries in the Korean popula-
tion with the goal of determining the optimal concentration
of anti-caries candidate substances and subsequently
developing oral hygiene products.14 The purpose of this
study was to determine the optimal concentrations of
deglycyrrhizinated licorice root extract (DG-LRE) in pre-
venting dental caries using the aforementioned bacterial
screening system.
Materials and methods
Preparation of deglycyrrhizinated licorice root
extract
Licorice root derived from G. uralensis was purchased from
a herbal drug market (Youngju, Korea). DG-LRE was thenprepared as previously described.8 Briefly, dried roots were
cut into thin slices, mixed with distilled water (distilled
water:dried root ratio of 20:1 [v/w]) and heated for 2 hours
in a round-bottom flask. Distilled water was removed, and
95% ethanol was added to the flask (95% ethanol:residue
ratio of 15:1 [v/w]). The mixture was heated at 78C for
2 hours, and the extract was evaporated. After adding 99%
ethanol, the solution was filtered using a custom-made
column (6.5 cm  60 cm) filled with Diaion HP-20 adsor-
bent (Mitsubishi Chemical Corporation, Minato-ku, Tokyo,
Japan). The final DG-LRE was passed through the column,
evaporated, and used for subsequent assays. Extracts were
suspended in dimethyl sulfoxide (DMSO; Sigma, St Louis,
MO, USA) at 50 mg/mL for further assays. Absence of gly-
cyrrhizin was confirmed using high-performance liquid
chromatography (data not shown).
Bacterial strains and culture condition
Clinical strains of S. mutans (KCOM 1054, KCOM 1111, KCOM
1113, KCOM 1116, KCOM 1126, KCOM 1128, KCOM 1136,
KCOM 1197, KCOM 1202, KCOM 1207, and KCOM 1217) as
well as S. sobrinus (KCOM 1157, KCOM 1196, and KCOM
1221) were obtained from the Korean Collection for Oral
Microbiology (KCOM, Gwangju, Korea). All strains were
cultured on a Todd Hewitt (TH, Difco, Franklin Lakes, NJ,
USA) broth in a 37C incubator in air containing 5% CO2.
Determination of minimum inhibitory
concentration and minimum bactericidal
concentration
The minimum inhibitory concentration (MIC) and minimum
bactericidal concentration (MBC) values were calculated
using a microdilution assay according to the Clinical and
Laboratory Standards Institute.15 Bacterial strains were
cultured in TH broth at 37C in an incubator for 24 hours
and added into a 96-well plate to a final concentration of
1  106 CFU/mL. DG-LRE solutions were then added to each
well to final concentrations of 32 mg/mL, 16 mg/mL, 8 mg/
mL, 4 mg/mL, 2 mg/mL, or 1 mg/mL. The final DMSO con-
centration in each well was 1%. Ampicillin 100 mg/mL was
used as the positive control and the culture medium of 1%
DMSO was used as the double-negative control. After
24 hours of incubation under suitable conditions, the lowest
concentration of DG-LRE that inhibited visible growth was
considered to be the MIC. To determine the MBC, 10 mL of
bacterial culture solution from each well at the MIC was
then diluted 100- or 10,000-fold and plated onto a TH agar
plate for each bacterial strain. The agar plate was incu-
bated in a 37C incubator for 48 hours and the bacterial
colonies were then counted. The concentration that killed
99.9% of the bacteria was considered the MBC. All experi-
ments were carried out in triplicate.
Time-kill kinetic assay
Time-kill kinetic assay was used to determine the bacteri-
cidal or bacteriostatic effects of the same MS strains under
varying DG-LRE concentrations. Time-kill curves were
assessed at the following DG-LRE concentrations: 32 mg/
216 S.-J. Ahn et almL, 16 mg/mL, 8 mg/mL, and 4 mg/mL. Control curves were
obtained in the culture medium for each strain. Bacteria
were inoculated in TH broth and incubated overnight in a
37C incubator. Liquid media containing the aforemen-
tioned DG-LRE concentrations were inoculated with
1  106 CFU/mL of an overnight culture and incubated in a
37C incubator. At 0 hours, 3 hours, 6 hours, 9 hours,
12 hours, and 24 hours after inoculation with bacteria, each
bacterial culture solution was diluted 100- or 10,000-fold
and plated onto a TH agar plate. The agar plate was then
incubated at a 37C for an additional 48 hours before the
bacterial colonies were counted.Table 1 MIC values of deglycyrrhizinated licorice root
extract against clinical strains of Streptococcus mutans and
Streptococcus sobrinus isolated from a Korean population.
Species and strains MIC (mg/mL) MBC (mg/mL)
S. mutans KCOM 1054 4 8
S. mutans KCOM 1111 4 8
S. mutans KCOM 1113 4 8
S. mutans KCOM 1116 8 8
S. mutans KCOM 1126 8 8
S. mutans KCOM 1128 4 16
S. mutans KCOM 1136 4 16
S. mutans KCOM 1197 4 8
S. mutans KCOM 1202 4 8
S. mutans KCOM 1207 8 8
S. mutans KCOM 1217 8 8
S. sobrinus KCOM 1157 4 8
S. sobrinus KCOM 1196 4 8
S. sobrinus KCOM 1221 4 8
MBC Z minimum bactericidal concentration; MIC Z minimum
inhibitory concentration.Biofilm formation assay
Unstimulated whole saliva was collected by the spitting
method from healthy volunteers as previously described.16
Each individual consented to the research protocol that had
been reviewed and approved by the institutional review
board of Seoul National University Hospital (Seoul, Korea).
Each saliva sample was centrifuged at 3500g for 10 mi-
nutes to remove any cellular debris and the resulting su-
pernatant was used after filter-sterilization through a
Stericup and Steritop (Millipore, Billerica, MA, USA).
To assess biofilm formation, each strain was grown in a
semi-defined biofilm medium with 18 mM glucose and 2 mM
sucrose as carbohydrate sources. Biofilm assays were done
using polystyrene 96-well (flat-bottom) cell culture clusters
(Costar 3595; Corning Inc, NY, USA). An overnight culture of
each strain was transferred to pre-warmed brain heart
infusion (BHI, Difco) broth and grown at 37C in a 5% CO2,
aerobic atmosphere to the mid exponential phase
(OD600 Z 0.5). The cultures were then diluted 100-fold in
pre-warmed biofilm medium containing DG-LRE at various
concentrations. A cell suspension containing only 1% DMSO
was used as the negative control.
Biofilm formation assays were performed with saliva-
coating. Each well was conditioned with 100 mL of unsti-
mulated whole saliva. The plates were incubated at 37C
for 2 hours with gentle shaking and then washed three
times with phosphate-buffered saline (pH Z 7.2). Imme-
diately after air drying for 30 minutes, the wells were
inoculated with 200 mL of the cell suspensions containing
various concentrations of DG-LRE (16 mg/mL, 8 mg/mL,
4 mg/mL, or 2 mg/mL). After inoculation, all plates were
incubated at 37C in a 5% CO2 atmosphere for 24 hours. The
culture medium was then decanted and the plates were
washed twice with 200 mL of sterile distilled water to
remove planktonic and loosely-bound cells. Adherent bac-
teria were stained with 50 mL of 0.1% crystal violet for
15 minutes. After rinsing twice with 200 mL of water, the
bound dye was extracted from the stained cells using 200 mL
of 99% ethanol. Biofilm formation was then quantified by
measuring the absorbance of the solution at 600 nm using a
spectrophotometer (Helios Beta, Thermo Scientific, Madi-
son, WI, USA). The relative biofilm formation was deter-
mined by the percentage rate using the following equation:
relative biofilm formation (biofilm formation rate, %) Z
(biofilm formation with 16 mg/mL, 8 mg/mL, 4 mg/mL, or
2 mg/mL of DG-LRE/biofilm formation without DG-
LRE)  100. All experiments were carried out in triplicate.Results
The MIC and MBC values of DG-LRE against the clinical
strains of MS ranged from 4 mg/mL to 8 mg/mL, and from
8 mg/mL to 16 mg/mL, respectively (Table 1). MBC values
against S. mutans and S. sobrinus were one to four times
higher than the MIC values. Antimicrobial effects of DG-
LRE increased in a concentration- and treatment time-
dependent manner (Fig. 1). Data from the time-kill ki-
netic assay revealed that a DG-LRE concentration of 8 mg/
mL had bactericidal effects on all MS strains except S.
mutans KCOM 1128 and S. mutans KCOM 1136. In the case
of S. mutans KCOM 1128 and S. mutans KCOM 1136,
bactericidal effects were shown at a DG-LRE concentration
of above 16 mg/mL.
The biofilm-inhibitory effects of DG-LRE were investi-
gated in the presence of saliva coating in order to simulate
the clinical situation. DG-LRE inhibited biofilm formation
above 50% in seven strains of S. mutans (KCOM 1113, KCOM
1126, KCOM 1128, KCOM 1136, KCOM 1202, KCOM 1207, and
KCOM 1217) and three strains of S. sobrinus (KCOM 1157,
KCOM 1196, and KCOM 1221) at 8 mg/mL of DG-LRE. DG-LRE
significantly decreased biofilm formation of MS ranging
from 57.6% to 92.8% at 16 mg/mL (Fig. 2).
Discussion
The results showed that DG-LRE concentration of 16 mg/mL
had bactericidal effect against MS strains used in this study
(Table 1 and Fig. 1). In our previous study, the antimicrobial
activity of DG-LRE was evaluated against S. mutans UA159,
where we found that both the MIC and MBC values of DG-
LRE were 8 g/mL.8 This reflects that some MS strains iso-
lated from the Korean population could be more resistant
than the reference MS strain isolated from the Western
population. Our prior work tested the antimicrobial effi-
ciencies of methanol-extracts from three plants against
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Figure 1 Time-kill curves of varying concentrations of deglycyrrhizinated licorice root extract against: (A) Streptococcus mutans
KCOM 1054; (B) S. mutans KCOM 1111; (C) S. mutans KCOM 1113; (D) S. mutans KCOM 1116; (E) S. mutans KCOM 1126; (F) S. mutans
KCOM 1128; (G) S. mutans KCOM 1136; (H) S. mutans KCOM 1197; (I) S. mutans KCOM 1202; (J) S. mutans KCOM 1207; (K) S. mutans
KCOM 1217; (L) Streptococcus sobrinus KCOM 1157; (M) S. sobrinus KCOM 1196; and (N) S. sobrinus KCOM 1221.
Optimal concentration of licorice root extract 217type strains (S. mutans ATCC 25175T and S. sobrinus ATCC
33478T) as well as 55 clinical strains (40 strains of S. mutans
and 15 strains of S. sobrinus). Interestingly, 11 clinical
strains of S. mutans and three clinical strains of S. sobrinus
had MBC90 values greater than two of three natural ex-
tracts.14 We selected those 14 clinical strains for the bac-
terial model mentioned earlier. In addition, the detection
percentages of S. mutans and S. sobrinus in a Koreansample (nZ 88) were 88% and 20%, respectively.17 This may
help to explain the MS strain imbalance for the bacterial
model. We previously quantified the optimal concentra-
tions of three essential oils and sophoraflavanone G through
this bacterial model.18,19 These resultsdcoupled with the
data presented heredsuggest that the bacteria model
system could be useful in determining an optimal concen-
tration of anti-caries agents in the development of oral
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Figure 1 (continued).
218 S.-J. Ahn et alhygiene products targeted specifically for the Korean
population.
The reduced biofilm formation may be mainly due to the
growth impairment of MS in the presence of DG-LFE,
because the MIC values of DG-LRE against the clinical
strains of MS ranged from 4 mg/mL to 8 mg/mL (Table 1).
The DG-LRE concentrations that inhibited the biofilm for-
mation of the MS, however, were higher than the MIC
values. The different inhibitory concentrations of DG-LRE
between biofilm formation and MIC might be due to the
glucan synthesis capacities of MS. In the presence of su-
crose, production of, and binding to, glucans effectively
promotes the vigorous biofilm formation of MS and the bulk
glucan layers constitute the biofilm’s matrix.16 In addition,
saliva coating enhances the glucan synthetic activities of
MS by facilitating the aggregation of glucosyltransferases
by salivary components.20 The polysaccharide biofilm
matrices may not only prevent DG-LRE from direct contact
with bacteria but also interfere in the diffusion of DG-LRE
into the matrices, which may reduce the antimicrobial
effects of DG-LRE against MS at a lower concentration of
DG-LRE.According to our previous data, the cell viability of
normal human gingival fibroblast cells for DG-LRE concen-
trations at 8 mg/mL and 16 mg/mL were 80% and 67%,
respectively.8 A classification of cytotoxicity has been
previously proposed; extracts were rated as severely,
moderately, or slightly cytotoxic when the activity relative
to controls was less than 30%, between 30% and 60%, or
greater than 60%, respectively.21 Considering the classifi-
cation, the concentration at 16 mg/mL of DG-LRE is slightly
cytotoxic to normal human gingival fibroblast cells.
Generally, the cell viability test for natural extracts on
human cells is performed in vitro. Human oral mucosa
in vivo may be more resistant to the natural extracts than
those in vitro. Such differences might be because oral tis-
sue cells in vivo can continuously be supplied nutrients via
blood supply, thereby enhancing repair mechanisms as
compared cells in vitro.13 DG-LRE concentrations of 16 mg/
mL in vivo might therefore be useful in the prevention of
dental caries. This, however, has to be proved by animal
and/or clinical studies.
In summary, the results in this paper suggest that DG-LRE
concentrations of 16 mg/mL could be useful in the
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Figure 2 Inhibitory effects of deglycyrrhizinated licorice root (DG-LRE) extract on the biofilm formation of clinical strains
of Streptococcus mutans (KCOM 1111, KCOM 1113, KCOM 1116, KCOM 1126, KCOM 1128, KCOM 1136, KCOM 1197, KCOM
1202, KCOM 1207, and KCOM 1217) and Streptococcus sobrinus (KCOM 1157, KCOM 1196, and KCOM 1221). The relative
biofilm formation was determined by the percentage rate using the following equation: relative biofilm formation (biofilm
formation rate, %) Z (biofilm formation with each various concentration of DG-LRE/biofilm formation without DG-
LRE)  100.
Optimal concentration of licorice root extract 219development of oral hygiene products for the prevention of
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